Cellebrite DI Balance Sheet Health

Financial Health criteria checks 6/6

Cellebrite DI has a total shareholder equity of $34.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $532.9M and $498.7M respectively. Cellebrite DI's EBIT is $33.4M making its interest coverage ratio -3.8. It has cash and short-term investments of $302.9M.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ratio-3.8x
CashUS$302.92m
EquityUS$34.21m
Total liabilitiesUS$498.67m
Total assetsUS$532.89m

Recent financial health updates

No updates

Recent updates

Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Mar 14
Cellebrite DI Ltd.'s (NASDAQ:CLBT) P/S Is Still On The Mark Following 28% Share Price Bounce

Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

Feb 18
Cellebrite DI Ltd. (NASDAQ:CLBT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$13.17

There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Jan 28
There's Reason For Concern Over Cellebrite DI Ltd.'s (NASDAQ:CLBT) Price

Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Nov 04
Is Cellebrite DI Ltd. (NASDAQ:CLBT) Trading At A 39% Discount?

Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

May 26
Calculating The Intrinsic Value Of Cellebrite DI Ltd. (NASDAQ:CLBT)

We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Apr 29
We Ran A Stock Scan For Earnings Growth And Cellebrite DI (NASDAQ:CLBT) Passed With Ease

Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Mar 16
Is Now The Time To Look At Buying Cellebrite DI Ltd. (NASDAQ:CLBT)?

Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Feb 16
Cellebrite DI Ltd. (NASDAQ:CLBT) Held Back By Insufficient Growth Even After Shares Climb 33%

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Feb 09
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Oct 18
Is There An Opportunity With Cellebrite DI Ltd.'s (NASDAQ:CLBT) 45% Undervaluation?

Cellebrite: A Niche Company With A Large TAM

Sep 30

Cellebrite DI Lowers Sights For 2022

Aug 30

Cellebrite Non-GAAP EPS of $0.00 misses by $0.03, revenue of $62.6M misses by $6.5M

Aug 11

Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Jul 08
Cellebrite DI Ltd.'s (NASDAQ:CLBT) Intrinsic Value Is Potentially 61% Above Its Share Price

Financial Position Analysis

Short Term Liabilities: CLBT's short term assets ($422.1M) exceed its short term liabilities ($253.8M).

Long Term Liabilities: CLBT's short term assets ($422.1M) exceed its long term liabilities ($244.8M).


Debt to Equity History and Analysis

Debt Level: CLBT is debt free.

Reducing Debt: CLBT has not had any debt for past 5 years.

Debt Coverage: CLBT has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CLBT has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.